CIK 0001827401 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in A1 · fiscal year ends 09/30
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-02 | 6-K | FORM 6-K | 2026-03-31 |
| 2026-10-01 | 6-K | FORM 6-K | 2026-09-30 |
| 2026-08-17 | 6-K | FORM 6-K | 2026-06-30 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-13 | S-8 | FORM S-8 | |
| 2026-08-12 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-02 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-06-03 | 6-K | FORM 6-K | 2026-03-31 |
| 2026-06-02 | 6-K | FORM 6-K | 2026-01-20 |
| 2026-05-28 | 6-K | 6-K | 2026-05-26 |
| 2026-05-20 | 6-K | FORM 6-K | 2026-03-31 |
| 2026-05-15 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-12 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-04-30 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-04-30 | 4 | 4 | 2026-04-28 |
| 2026-02-17 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-02-17 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-02-17 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-02-13 | 6-K | FORM 6-K | 2025-12-31 |
| 2026-02-06 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-01-09 | 6-K | FORM 6-K | 2026-01-09 |
| 2026-01-09 | 6-K | FORM 6-K | 2026-01-07 |
| 2026-01-09 | 424B5 | FORM 424B5 |
Forms on file (last 1,000): 6-K 85, SCHEDULE 13G/A 18, D 14, UPLOAD 7, SCHEDULE 13G 6, CORRESP 6, SC 13G 6, 20-F 4. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=DRUG (0.002 USD), /gw/filings/filings?ticker=DRUG&form=8-K, /gw/filings/facts?ticker=DRUG&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange